Sagoso, Aillie Celestine O.
HRN: 22-81-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2023
CEFTRIAXONE 1G (VIAL)
04/04/2023
04/10/2023
750 MG
IV DRIP
Q24
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes